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Abstract
Development of the fundamental and clinical «regenerative medicine» is based on the progress
of gene, stem cell and gene-cell biotechnologies. However, the reliable preclinical investigations
on animal models and more over clinical trials stay far away from the available nowadays gene
and cell constructions. Neuroscience is one of the fast growing fields of knowledge in biology
and medicine. Pioneer experiments in neuroscience promises breakthrough in the innovative
methods for treatment of neurodegenerative diseases in near future. This review addresses
strategies for gene-cell therapy of neurodegenerative diseases by the example of amyotrophic
lateral sclerosis. Precisely gene modification of mononuclear fraction of umbilical cord blood
cells  (UCBC)  by  dual  cassette  plasmid  vectors  is  observed.  Based  on  our  own results  of
transplantation of genetically modified UCBC overexpressing recombinant neural cell adhesion
molecule L1, vascular endothelial growth factor, fibroblast growth factor 2, and glial derived
neurotrophic factor in different combinations we provide the experimental data for usefulness of
transplantation of gene modified UCBC for treating neurodegenerative diseases. In the review
we discuss the efficacy of gene modification of UCBC not only for secretion of recombinant
proteins, but in increasing of transplanted cells survivability, their migration possibilities and
capability to differentiate in endothelial, microglial and macroglial cell types.
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